US 10010534
Intravenous formulation and LC/MS/MS analysis method for GMC1
granted A61KA61K31/4184A61K45/06
Quick answer
US patent 10010534 (Intravenous formulation and LC/MS/MS analysis method for GMC1) held by The Board of Regents of the University of Texas System expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/4184, A61K45/06, A61K47/10, A61K47/14